The Fund aims to provide a higher yield than that of the FTSE All-Share Index with some long-term growth.
Name | % Net Assets |
---|---|
BP USD0.25 | 10.8% |
Royal Dutch Shell B | 8.2% |
GlaxoSmithKline | 7.2% |
Vodafone | 7.1% |
British American Tobacco | 4.8% |
AstraZeneca | 4.8% |
Scottish & Southern | 4.5% |
HSBC | 4.2% |
Rio Tinto | 4.1% |
National Grid | 4.0% |
Key | % Net Assets |
---|---|
BP USD0.25 | 10.8% |
Royal Dutch Shell B | 8.2% |
GlaxoSmithKline | 7.2% |
Vodafone | 7.1% |
Other | 66.7% |
Date | 13-Nov-2024 |
---|---|
NAV | 208.00p |
Currency | GBP |
Change | -1.50p |
% | -0.72% |
YTD change | 14.90p |
YTD % | 7.72% |
Fund Inception | 05/11/1968 |
---|---|
Fund Manager | Julian Cane |
TER | 1.80 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research